Vicore Pharma - Phase two Covid results show 50% lower occur
-
We are long Vicore Pharma. The company is now recruiting for its COVID-19 phase 3 trial is now recruiting in 14 hospitals globally.
Vicore is showing steady progress while continuing to be fairly hidden/unknown and trade at a strong discount in our view, even when considering solely its potential in idiopathic pulmonary fibrosis (IPF).
Vicore Pharma – Phase two Covid results show 50% lower occurrence of COVID complications
Vicore Pharma today announced positive results of their Covid drug Phase 2 study. I enclosed below a summary from Pareto Research published today. We are long Vicore Pharma. The company is now recruiting for its COVID-19 phase 3 trial is now recruiting in 14 hospitals globally. Vicore is showing steady progress while continuing to be…
Fit Investment Ideas (fitinvestmentideas.com)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind